Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2005, Vol. 105, No. 10, pp. 4127-4134.
Prepublished online as a Blood First Edition Paper on January 27, 2005; DOI 10.1182/blood-2004-05-1726.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-05-1726v1
105/10/4127    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hainz, U.
Right arrow Articles by Heitger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hainz, U.
Right arrow Articles by Heitger, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 5, 2004
Accepted January 25, 2005

Monocyte-mediated T cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem cell transplantation

Ursula Hainz, Petra Obexer, Christiana Winkler, Peter Sedlmayr, Osamu Takikawa, Hildegard Greinix, Anita Lawitschka, Ulrike Potschger, Dietmar Fuchs, Stephan Ladisch, and Andreas Heitger*

Children's Cancer Research Institute, St. Anna Children's Hospital, Vienna, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
Institute of Medical Chemistry and Biochemistry, Innsbruck Medical University and Ludwig Boltzmann Institute of AIDS-Research, Innsbruck, Austria
Institute of Histology and Embryology, Medical University of Graz, Graz, Austria
Central Research Institute, Department of Pharmacology and Molecular Biochemistry, Hokkaido University, Sapporo, Japan
Department of Medicine I, Vienna General Hospital, Vienna, Austria
Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, Washington, DC, USA

* Corresponding author; email: andreas.heitger{at}ccri.at.

T-cell dysfunction after human hematopoietic stem cell transplantation (HSCT) is generally attributed to intrinsic T-cell defects. Here we show that the characteristic impaired proliferative responses to polyclonal stimulation of post-HSCT PBMC were markedly (four-fold) improved by T-cell enrichment. Conversely, addback of post-HSCT monocytes to these enriched T cells dampened their proliferative responses, suggesting that post-HSCT monocytes effectively mediate T-cell suppression. As a mechanism possibly contributing to monocyte-mediated T-cell suppression, we investigated monocyte tryptophan catabolism by indoleamine 2,3-dioxygenase into kynurenine, which has been implicated in regulating T-cell responses. Compared to controls, all post-HSCT monocyte-containing cell cultures (total PBMC, monocytes, and monocyte/T-cell co-cultures), but not monocyte-depleted populations, secreted elevated amounts of kynurenine. Blockade of tryptophan catabolism improved the proliferative responses. The slightly increased kynurenine release and substantial release of neopterin by unstimulated post-HSCT monocytes suggests that they were in a state of continuous activation. Superimposed on this state, stimulation of these cells caused a striking, additional increase (ten-fold) in kynurenine release, and they triggered marked apoptosis of autologous post-HSCT T-cells. We conclude that the amplified kynurenine release by post-HSCT monocytes, particularly induced upon stimulation, may underlie their suppressor activity that in turn may contribute to the depressed T-cell immune responses after HSCT.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
B. Jurgens, U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger
Interferon-{gamma}-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
Blood, October 8, 2009; 114(15): 3235 - 3243.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Orabona, P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al.
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
Blood, April 1, 2006; 107(7): 2846 - 2854.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020